Elimusertib (BAY-1895344) is a potent, orally active and selective ATR inhibitor with an IC50 of 7 nM. Elimusertib has anti-tumor activity. Elimusertib can be used for the research of solid tumors and lymphomas.
ATM/ATR Inhibitors Related Products:
Dactolisib; KU-55933; Wortmannin; CP-466722; AZ32; Mirin; KU-60019